Overview
Shinichiro Okada practices practicing medicine in Yokosuka, Japan.
Their clinical expertise encompasses Retroperitoneal Inflammation, Toxic Shock Syndrome, and Ileostomy.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shinichiro Okada
Is Shinichiro Okada a top-rated expert for Retroperitoneal Inflammation?
MediFind is an objective health platform that identifies experts based on real-world data. Shinichiro Okada is classified as an Experienced expert for Retroperitoneal Inflammation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shinichiro Okada participate in research or clinical trials?
Yes. Shinichiro Okada has published 11 articles and abstracts on conditions like Retroperitoneal Inflammation. You can view a list of Shinichiro Okada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- IleostomyOkada isExperienced. Learn about Ileostomy.
- Retroperitoneal InflammationOkada isExperienced. Learn about Retroperitoneal Inflammation.
- Toxic Shock SyndromeOkada isExperienced. Learn about Toxic Shock Syndrome.